Plesner advised Zealand Pharma on the deal. NASDAQ Copenhagen-listed biotech Zealand Pharma, signed a finance contract agreement with The European Investment Bank concerning a EUR 90 million term...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here